Micro-Comparison
    Side Effects

    Semaglutide vs Tirzepatide for Hair Loss

    Hair thinning is one of the most distressing side effects of rapid weight loss. Here is how semaglutide and tirzepatide compare and what you can do about it.

    Published: April 3, 2026-8 min read

    Medical Disclaimer: This comparison is for informational purposes only. Consult your healthcare provider for personalized guidance.

    Hair loss is one of the most googled side effects of GLP-1 medications. If you are choosing between semaglutide and tirzepatide and hair loss is a concern, here is what the evidence actually shows.

    The Clinical Trial Data

    MetricSemaglutideTirzepatide
    Hair loss (alopecia) reported~3% (STEP 1)4-6% (SURMOUNT-1)
    Placebo rate~1%~1%
    Average weight loss~15%~21%
    OnsetMonths 2-4Months 2-4
    Resolution3-6 months after stabilization3-6 months after stabilization

    Why It Happens: Telogen Effluvium

    The hair loss seen with GLP-1 medications is not caused by the medication directly. It is caused by rapid weight loss and caloric deficit, a condition called telogen effluvium:

    • Normally, 85-90% of hair is in the growth phase (anagen) and 10-15% is in the resting/shedding phase (telogen)
    • During significant caloric deficit, the body shifts more hair follicles into the resting phase to conserve energy
    • 2-3 months later, these hairs shed simultaneously, causing noticeable thinning
    • Because tirzepatide typically produces more weight loss, it may trigger slightly more hair shedding, but this is a weight-loss effect, not a drug-specific effect

    Prevention Strategies

    Hair Loss Prevention Protocol

    • Protein: Aim for 80-120g daily. Hair is made of protein (keratin). Inadequate protein worsens shedding
    • Iron: Get ferritin levels checked. Low iron is a common cause of hair loss that compounds with weight-loss shedding
    • Biotin: 2,500-5,000 mcg daily may support hair regrowth
    • Zinc: 15-30mg daily supports hair follicle health
    • Vitamin D: Deficiency is common and contributes to hair loss
    • Collagen: 10-15g daily may support hair and skin health
    • Slower titration: Gradual weight loss reduces the body's stress response

    The Bottom Line

    Our Assessment

    Neither medication is clearly better or worse for hair loss. The key factor is how much and how fast you lose weight, not which medication you take. Focus on adequate protein and micronutrient intake to minimize hair shedding on either medication. Hair loss from weight loss is temporary and resolves after weight stabilization.

    Frequently Asked Questions

    Does semaglutide cause more hair loss than tirzepatide?

    Clinical trial data shows similar rates of hair loss for both medications. In the STEP trials, about 3% of semaglutide patients reported hair loss. In SURMOUNT trials, 4-6% of tirzepatide patients reported it. Hair loss is primarily related to the rate and amount of weight loss rather than the specific medication.

    Why does hair fall out on GLP-1 medications?

    Hair loss during GLP-1 treatment is a condition called telogen effluvium, caused by rapid weight loss and caloric deficit rather than the medication itself. When the body experiences significant caloric restriction, it shifts resources away from hair growth. This is temporary and typically resolves 3-6 months after weight stabilization.

    How can I prevent hair loss on GLP-1?

    Maintain adequate protein intake (at least 60-80g daily, ideally more), take a multivitamin with biotin, iron, zinc, and vitamin D, avoid crash dieting on top of medication, and consider collagen supplements. Slower weight loss through gradual dose titration may also reduce hair shedding.

    Is GLP-1 hair loss permanent?

    No. Telogen effluvium from weight loss is temporary. Hair typically regrows within 6-12 months after weight stabilizes. If hair loss is severe or does not improve, consult a dermatologist to rule out other causes.

    Find Your Best GLP-1 Fit with Trimi

    Our clinicians help you choose the right medication and dosing strategy for your goals and concerns.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 7, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Was this article helpful?

    Keep Reading

    Complete cost breakdown of semaglutide, tirzepatide, and retatrutide. Brand-name vs. compounded pricing, insurance coverage, and cost-per-pound-lost analysis.

    Complete side effect comparison of semaglutide, tirzepatide, and retatrutide. Nausea, GI issues, hair loss, fatigue, and unique side effects of each medication.

    Read our guide on Compounding Vs Manufacturing.

    A structured decision framework to choose between semaglutide, tirzepatide, and retatrutide based on your health profile, goals, budget, and risk tolerance.